
HIV-IN-6
CAS No. 301357-74-4
HIV-IN-6( —— )
Catalog No. M35590 CAS No. 301357-74-4
HIV-IN-6 is an HIV viral inhibitor that inhibits the replication of the HIV virus.HIV-IN-6 has anti-HIV viral activity and works by targeting Src family kinases (SFK) (e.g., Hck) that interact with the viral Nef protein.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 56 | In Stock |
![]() ![]() |
10MG | 92 | In Stock |
![]() ![]() |
25MG | 181 | In Stock |
![]() ![]() |
50MG | 293 | In Stock |
![]() ![]() |
100MG | 426 | In Stock |
![]() ![]() |
500MG | 888 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameHIV-IN-6
-
NoteResearch use only, not for human use.
-
Brief DescriptionHIV-IN-6 is an HIV viral inhibitor that inhibits the replication of the HIV virus.HIV-IN-6 has anti-HIV viral activity and works by targeting Src family kinases (SFK) (e.g., Hck) that interact with the viral Nef protein.
-
DescriptionHIV-IN-6 is a HIV-Ⅰ viral replication inhibitor by targeting Src family kinases (SFK) that interact with Nef protein of the virus, such as Hck.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV Protease
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number301357-74-4
-
Formula Weight392.43
-
Molecular FormulaC20H16N4O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (254.82 mM; Ultrasonic )
-
SMILESOc1cccc(Nc2nc3ccccc3nc2NS(=O)(=O)c2ccccc2)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Emert-Sedlak, et al. Targeting an hiv-1 nef-host cell kinase complex.
molnova catalog



related products
-
N.41
N.41 (HIV inhibitor N.41, Vif inhibitor N.41) is a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G (A3G) protein (IC50=2.2 uM).
-
BMS-955176
BMS-955176 (GSK-3532795) is a second-generation HIV-1 maturation inhibitor that exhibits potent activity (EC50=3.9±3.4 nM) against a library (n=87) of gag/pr recombinant viruses.
-
HIV-1 inhibitor 5b
HIV-1 inhibitor 5b is a novel anti-HIV-1 compound that inhibits HIV-1 JR-CSF with EC50 of 1 nM without significant cytotoxicity (CC50>20 uM).